PureTech News

PureTech to Present at the Barclays Global Healthcare Conference

PureTech Founded Entity Sonde Health and Massachusetts General Hospital Selected for National Institute on Aging Study to Examine Use of Voice in Remote Detection and Monitoring of Mild Cognitive Impairment Including Frontotemporal Disorders (FTD)

PureTech to Advance LYT-300 (Oral Allopregnanolone) for the Potential Treatment of Anxiety Disorders and Postpartum Depression

PureTech to Present at the SVB Securities Global Biopharma Conference

PureTech Founded Entity Akili Announces Pivotal Trial of EndeavorRx® in Adolescents with ADHD Shows Robust Improvements in Attention and Broader Clinical Outcomes

PureTech Provides End of Year Report on Key Progress

PureTech's LYT-300 (Oral Allopregnanolone) Demonstrates Oral Bioavailability, Tolerability and GABAA Receptor Target Engagement in Healthy Volunteers

PureTech to Present at 41st Annual J.P. Morgan Healthcare Conference

PureTech Presents Data for LYT-200 Targeting Galectin-9 in Preclinical Leukemia Cancer Models at the 64th American Society of Hematology (ASH) Annual Meeting

PureTech Founded Entity Sonde Health Raises $19.25 Million Series B for Voice-Based Health Monitoring